MTOR and cancer: In summary, it has been shown that targeting mTOR signaling in intestinal epithelial cells controls the recruitment and activation of innate inflammatory macrophages and neutrophils, thereby contributing to the onset and development of acute experimental ulcerative colitis and colitis-associated cancer.